Search results
Author(s):
Marjorie L King
Added:
3 years ago
In this era of healthcare financial reform, there is a growing consensus that treatments should be cost-effective, decrease disability, and improve survival. There is also increasing recognition that healthcare should be co-ordinated among clinicians and care settings, and that patients should be involved in the decision-making process. Cardiac rehabilitation (CR) programs are ideally situated to…
View more
Foreword
Author(s):
James T Dove
Added:
3 years ago
Article
Author(s):
Shahana Uddin
,
Rathai Anandanadesan
,
Richard Trimlett
,
et al
Added:
1 year ago
Author(s):
Aniket S Rali
,
Amy Butcher
,
Ryan J Tedford
,
et al
Added:
1 year ago
Author(s):
Karl B Kern
,
Sergio Timerman
,
José Antônio Franchini Ramires
Added:
3 years ago
Cardiocerebral resuscitation (CCR) is a relatively new approach to the resuscitation of patients with out-of-hospital cardiac arrest (see Figure 1). By 2003, both the accumulated resuscitation research data and our own local clinical experience in Tucson, Arizona clearly indicated that interruptions of chest compressions had a negative effect on survival. Accordingly, in November 2003 in co…
View more
Author(s):
Randall S Stafford
,
Veronica Monti
,
Jun Ma
Added:
3 years ago
Cardiovascular disease (CVD), including myocardial infarction and stroke, is the leading cause of morbidity and mortality in the US. A broad array of randomized trials have demonstrated the benefits of low doses of aspirin (75-325mg)1,2 for both the primary3-7 and secondary8-11 prevention of CVD. Most trials demonstrate a 15-40% reduction in cardiovascular events with chronic aspirin use.Aspirin…
View more
Author(s):
Randall S Stafford
,
Veronica Monti
,
Jun Ma
Added:
3 years ago
Cardiovascular disease (CVD), including myocardial infarction and stroke, is the leading cause of morbidity and mortality in the US. A broad array of randomized trials have demonstrated the benefits of low doses of aspirin (75-325mg)1,2 for both the primary3-7 and secondary8-11 prevention of CVD. Most trials demonstrate a 15-40% reduction in cardiovascular events with chronic aspirin use.Aspirin…
View more
Author(s):
Mathew S Maurer
Added:
3 years ago
Cardiac output (CO) is a fundamental measure for the assessment of cardiac performance and is applied widely to detect the presence of cardiovascular disease and monitor its progression, as well as to monitor patients in challenging hemodynamic circumstances and to optimize therapy. CO is a key parameter in characterizing a patient’s hemodynamic state. For example, a notable characteristic of…
View more
Gregg C Fonarow
Research Area(s) / Expertise:
Author
Expertise
Alexander G Truesdell
Research Area(s) / Expertise:
Author